IOSP vs. ALB, NEU, CE, BCPC, SXT, FUL, ASH, KWR, MTX, and SCL
Should you be buying Innospec stock or one of its competitors? The main competitors of Innospec include Albemarle (ALB), NewMarket (NEU), Celanese (CE), Balchem (BCPC), Sensient Technologies (SXT), H.B. Fuller (FUL), Ashland (ASH), Quaker Chemical (KWR), Minerals Technologies (MTX), and Stepan (SCL). These companies are all part of the "specialty chemicals" industry.
Innospec vs.
Innospec (NASDAQ:IOSP) and Albemarle (NYSE:ALB) are both mid-cap basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.
96.6% of Innospec shares are owned by institutional investors. Comparatively, 92.9% of Albemarle shares are owned by institutional investors. 1.3% of Innospec shares are owned by insiders. Comparatively, 0.3% of Albemarle shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Albemarle has a consensus target price of $91.62, indicating a potential upside of 62.14%. Given Albemarle's higher probable upside, analysts plainly believe Albemarle is more favorable than Innospec.
Innospec has higher earnings, but lower revenue than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.
In the previous week, Innospec had 4 more articles in the media than Albemarle. MarketBeat recorded 10 mentions for Innospec and 6 mentions for Albemarle. Innospec's average media sentiment score of 1.01 beat Albemarle's score of 0.26 indicating that Innospec is being referred to more favorably in the media.
Albemarle received 440 more outperform votes than Innospec when rated by MarketBeat users. However, 65.95% of users gave Innospec an outperform vote while only 61.78% of users gave Albemarle an outperform vote.
Innospec pays an annual dividend of $1.68 per share and has a dividend yield of 2.0%. Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 2.9%. Innospec pays out 155.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Albemarle pays out -14.6% of its earnings in the form of a dividend. Innospec has raised its dividend for 11 consecutive years and Albemarle has raised its dividend for 30 consecutive years. Albemarle is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Innospec has a net margin of 1.93% compared to Albemarle's net margin of -21.93%. Innospec's return on equity of 12.27% beat Albemarle's return on equity.
Innospec has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, Albemarle has a beta of 1.71, indicating that its stock price is 71% more volatile than the S&P 500.
Summary
Innospec beats Albemarle on 13 of the 22 factors compared between the two stocks.
Get Innospec News Delivered to You Automatically
Sign up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Innospec Competitors List
Related Companies and Tools
This page (NASDAQ:IOSP) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy IOSP Stock Free IOSP Stock Alerts